The private equity arm of investment bank Goldman Sachs and Government of Singapore Investment Corporation (GIC) have invested US$100 million in iKang Guobin, a Chinese healthcare company. iKang, which operates healthcare treatment centers in China, plans to use the capital to accelerate the company’s expansion into third- and fourth-tier Chinese cities.